{"id":14697,"date":"2019-02-04T07:00:15","date_gmt":"2019-02-04T06:00:15","guid":{"rendered":"https:\/\/www.andrewalliance.com\/?p=14697"},"modified":"2022-02-25T09:48:49","modified_gmt":"2022-02-25T08:48:49","slug":"macherey-nagel-gmbh-co-kg-and-andrew-alliance-sign-co-marketing-agreement","status":"publish","type":"post","link":"https:\/\/www.andrewalliance.com\/fr\/press\/macherey-nagel-gmbh-co-kg-and-andrew-alliance-sign-co-marketing-agreement\/","title":{"rendered":"Macherey-Nagel GmbH &#038; Co. KG and Andrew Alliance Sign Co-Marketing Agreement"},"content":{"rendered":"<p><span class=\"xn-location\">GENEVA<\/span>,\u00a0<span class=\"xn-chron\">February 4, 2019<\/span>\u00a0\/PRNewswire\/ &#8212;<\/p>\n<p>Macherey-Nagel GmbH &amp; Co. KG and\u00a0<span class=\"xn-person\">Andrew Alliance<\/span>\u00a0today announced they have signed an agreement stating that they are working together to develop an automated solution for the preparation of transfection grade plasmid DNA. \u00a0Under the co-marketing agreement, Macherey-Nagel will combine its existing NucleoBond\u00ae Xtra Midi kits with\u00a0<span class=\"xn-person\">Andrew Alliance&#8217;s<\/span>\u00a0OneLab software platform and Andrew+ robot.<\/p>\n<p>&#8220;Dr.\u00a0<span class=\"xn-person\">Achim Leitzke<\/span>\u00a0(General Manager Sales and Marketing, MACHEREY-NAGEL,\u00a0<span class=\"xn-location\">Germany<\/span>) stated &#8220;Biotechnology in general and biomedical and biopharmaceutical research in particular are increasingly moving towards workflow automation, freeing up valuable human resources for creative and productive work. Further, reliability and traceability are gaining in importance. As a pioneer in the technology of nucleic acid purification, MACHEREY-NAGEL has extensive experience in automated plasmid preps. Likewise, throughout the years, we have always provided innovative solutions and state of the art methods in the field of plasmid midi processing based on anion exchange chromatography. In order to remain on the cutting edge of a rapidly evolving market, we need a reliable and competent automation partner. We believe that we have found such a partner in\u00a0<span class=\"xn-person\">Andrew Alliance<\/span>\u00a0and that together, our experts can develop a truly great product for automated plasmid midi prep processing.&#8221;<\/p>\n<p><span class=\"xn-person\">Piero Zucchelli<\/span>, CEO and Co-Founder of\u00a0<span class=\"xn-person\">Andrew Alliance<\/span>\u00a0stated, &#8220;Having transfection grade plasmid DNA available is critical to many of today&#8217;s high value biopharmaceutical applications. \u00a0Working with Macherey-Nagel and their proven anion-exchange technology will allow us to develop a cost effective automation solution for this important process.&#8221;<\/p>\n<p>For more information about the Macherey-Nagel NucleoBond\u00ae technology, visit\u00a0<a href=\"http:\/\/www.mn-net.com\/\" rel=\"nofollow noopener\" target=\"_blank\">http:\/\/www.mn-net.com<\/a><\/p>\n<p>For more information about\u00a0<span class=\"xn-person\">Andrew Alliance<\/span>, OneLab and the Andrew+, please contact\u00a0<a href=\"mailto:contact@andrewalliance.com\" rel=\"nofollow\">contact@andrewalliance.com<\/a><\/p>\n<p>SOURCE Andrew Alliance SA<\/p>","protected":false},"excerpt":{"rendered":"<p>Macherey-Nagel GmbH &#038; Co. KG and\u00a0Andrew Alliance\u00a0today announced they have signed an agreement stating that they are working together to develop an automated solution for the preparation of transfection grade plasmid DNA. \u00a0<\/p>","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-14697","post","type-post","status-publish","format-standard","hentry","category-press"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.andrewalliance.com\/fr\/wp-json\/wp\/v2\/posts\/14697","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.andrewalliance.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.andrewalliance.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.andrewalliance.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.andrewalliance.com\/fr\/wp-json\/wp\/v2\/comments?post=14697"}],"version-history":[{"count":0,"href":"https:\/\/www.andrewalliance.com\/fr\/wp-json\/wp\/v2\/posts\/14697\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.andrewalliance.com\/fr\/wp-json\/wp\/v2\/media?parent=14697"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.andrewalliance.com\/fr\/wp-json\/wp\/v2\/categories?post=14697"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.andrewalliance.com\/fr\/wp-json\/wp\/v2\/tags?post=14697"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}